Platelets

Papers
(The TQCC of Platelets is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study196
Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count109
Immunothrombosis and thromboinflammation in host defense and disease82
Hemostatic laboratory derangements in COVID-19 with a focus on platelet count61
Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)60
A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients50
Platelet Rich Plasma in Orthopedic Surgical Medicine.40
Histological comparison of Platelet rich fibrin clots prepared by fixed-angle versus horizontal centrifugation36
PRP in wound healing applications34
Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity33
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors33
Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine32
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty30
Platelet rich plasma in oral and maxillofacial surgery from the perspective of composition29
Role of platelets and megakaryocytes in adaptive immunity28
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients28
Thrombus heterogeneity in ischemic stroke28
In vivo evaluation of the biocompatibility and biodegradation of a new denatured plasma membrane combined with liquid PRF (Alb-PRF)28
Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases27
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure26
Rotational thromboelastometry (ROTEM) profiling of COVID–19 patients24
The thrombopoietin receptor: revisiting the master regulator of platelet production23
Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review22
Neonatal platelet physiology and implications for transfusion21
Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension21
Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous 20
Platelets and viruses20
Isolation of murine bone marrow by centrifugation or flushing for the analysis of hematopoietic cells – a comparative study19
Platelet removal by single-step centrifugation19
Platelet-rich plasma promotes bone formation, restrains adipogenesis and accelerates vascularization to relieve steroids-induced osteonecrosis of the femoral head19
The structure of CLEC-2: mechanisms of dimerization and higher-order clustering18
Application of Platelet Rich Fibrin in Tissue Engineering: Focus on Bone Regeneration18
Human platelet lysates for human cell propagation17
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count17
MicroRNA-126 is a regulator of platelet-supported thrombin generation17
Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses17
Platelets and renal failure in the SARS-CoV-2 syndrome16
Mouse laser injury models: variations on a theme16
Lymphatic blood filling in CLEC-2-deficient mouse models16
Platelet–leukocyte interactions in the pathogenesis of viral infections16
Novel antiplatelet targets in the treatment of acute coronary syndromes16
Zinc regulates reactive oxygen species generation in platelets16
Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia15
Bioinspired artificial platelets: past, present and future15
Immobilized collagen prevents shedding and induces sustained GPVI clustering and signaling in platelets15
Use of electron microscopy to study platelets and thrombi14
An adaptable analysis workflow for characterization of platelet spreading and morphology14
Changes in megakaryopoiesis over ontogeny and their implications in health and disease13
Structure-function relationship of the platelet glycoprotein VI (GPVI) receptor: does it matter if it is a dimer or monomer?13
Cytosolic and mitochondrial Ca2+ signaling in procoagulant platelets13
The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis13
Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study12
The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis12
Alterations in platelets during SARS-CoV-2 infection12
EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling12
Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib12
Studies on platelet rich plasma - new editorial policy for “Platelets”11
Antiplatelet drugs and liver fibrosis11
Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets11
Left ventricular assist device implantation causes platelet dysfunction and proinflammatory platelet-neutrophil interaction11
Frozen and cold-stored platelets: reconsidered platelet products11
Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors11
Platelet-rich plasma loaded with antibiotics as an affiliated treatment for infected bone defect by combining wound healing property and antibacterial activity11
Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline11
Platelet count and function in umbilical cord blood versus peripheral blood in term neonates11
Platelet reticulated forms, size indexes and functional activity. Interactions in healthy volunteers.11
In vitro evaluation of platelet extracellular vesicles (PEVs) for corneal endothelial regeneration11
Diagnostic and prognostic role of platelets in patients with sepsis and septic shock10
Targeting platelet inhibition receptors for novel therapies: PECAM-1 and G6b-B10
In vitro-derived platelets: the challenges we will have to face to assess quality and safety10
Release of α-granule contents during platelet activation10
ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction10
Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study10
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function10
Impact of high on-treatment platelet reactivity after angioplasty in patients with peripheral arterial disease10
Platelet-derived microparticles stimulated by anti-β 2 GPI/β 2 GPI complexes induce pyroptosis of endothelial cells in antiphospho10
Higher body mass index raises immature platelet count: potential contribution to obesity-related thrombosis9
Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-29
Immature platelet indices alongside procalcitonin for sensitive and specific identification of bacteremia in the intensive care unit9
Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors9
Platelet Function Assays for the Diagnosis of Aspirin Resistance9
Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis9
Mechanisms of platelet release: in vivo studies and in vitro modeling9
High extracellular phosphate increases platelet polyphosphate content9
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy9
A proprietary GMP human platelet lysate for the expansion of dermal fibroblasts for clinical applications9
Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-199
Zinc: an endogenous and exogenous regulator of platelet function during hemostasis and thrombosis9
Effect of differently coated silver nanoparticles on hemostasis8
Whole blood flow cytometry protocol for the assessment of platelet phenotype, function, and cellular interactions8
Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia8
Platelet-derived respiratory-competent mitochondria transfer to mesenchymal stem cells to promote wound healing via metabolic reprogramming8
Platelets in dengue infection: more than a numbers game8
High-efficiency unassisted transfection of platelets with naked double-stranded miRNAs modulates signal-activated translation and platelet function8
The enigmatic nature of the triggering receptor expressed in myeloid cells -1 (TLT- 1)8
Factor Xa and thrombin induce endothelial progenitor cell activation. The effect of direct oral anticoagulants8
The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary int8
Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases8
Injectable platelet-rich fibrin positively regulates osteogenic differentiation of stem cells from implant hole via the ERK1/2 pathway7
The basement membrane protein nidogen-1 supports platelet adhesion and activation7
Optimized tool for evaluation of platelet function measured by impedance aggregometry7
Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia7
Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis7
Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS su7
Pathogen inactivation of platelets for transfusion7
Platelets: bridging thrombosis and inflammation7
Enrichment of plasma in platelets and extracellular vesicles by the counterflow to erythrocyte settling7
Statins potentiate the antibacterial effect of platelets on Staphylococcus aureus7
The potency of selatogrel, a reversible antagonist of the P2Y12 receptor, is affected by calcium concentration7
Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention7
GPIb-IX-V and platelet clearance7
Characteristics of L-PRP preparations for treating Achilles tendon rupture within the PATH-2 study7
P2X1: a unique platelet receptor with a key role in thromboinflammation7
Structural analysis of resting mouse platelets by 3D-EM reveals an unexpected variation in α-granule shape7
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology7
Evolution of platelet activation parameters during septic shock in intensive care unit7
New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience7
The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy7
0.027596950531006